Development of insulin resistance in the JCR:LA-cp rat: Role of triacylglycerols and effects of MEDICA 16

Diabetes

Volumn 47, Issue 5, 1998, Pages 770-778

  Russell, James C ^a   Shillabeer, Gillian ^b   Bar Tana, Jacob ^e   Lau, David C W ^b   Richardson, Mary ^c   Wenzel, Leanne M ^a   Graham, Sandra E ^a   Dolphin, Peter J ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3,3,14,14 TETRAMETHYLHEXADECANEDIOIC ACID; TRIACYLGLYCEROL;

ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE METABOLISM; HYPERLIPIDEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTILIPEMIC AGENTS; DEOXYGLUCOSE; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; METABOLIC CLEARANCE RATE; MICROSCOPY, ELECTRON; MUSCLES; OBESITY; PALMITIC ACIDS; RATS; RATS, INBRED STRAINS; SYNDROME; TISSUE DISTRIBUTION; TRIGLYCERIDES;

EID: 0031894623     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.770     Document Type: Article

References (39)

1. Reaven GM, Chen YD: Insulin resistance, its consequences, and coronary heart disease. Circulation 93:1780-1783, 1996
2. Taegtmeyer H: Insulin resistance and atherosclerosis: common roots for two common diseases. Circulation 93:1777-1779, 1996
3. Steiner G: Hyperinsulinemia and hypertriglyceridemia. J Int Med 736 (Suppl.):23-26, 1994
4. Steiner G: Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. Am J Cardiol 57 (Suppl.):27G-30G, 1986
5. Hirata A, Shimamoto K, Masuda A, Miyazaki Y, Fukuoka M, Iimura O: Influence of aging on insulin sensitivity in essential hypertensives and normotensives. Hypertens Res 18:307-311, 1995
6. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
7. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
8. Pénicaud L, Ferre P, Terretaz J, Kinebanyan MF, Leturque A, Doré E, Girard J, Jeanrenaud B, Picon L: Development of obesity in Zucker rats: early insulin resistance in muscles but normal sensitivity in white adipose tissue. Diabetes 36:626-631, 1987
9. Bodkin N, Metzger B, Hansen B: Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 256:E676-E681, 1989
10. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlein LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403, 1991
11. Phillips DIW, Caddy S, Fielding BA, Frayne KN, Taylor R: Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45:947-950, 1996
12. Koletsky S: Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:129-142, 1975
13. Russell JC: The atherosclerosis-prone JCR:LA-corpulent rat. In Atherosclerosis X: Proceedings of the 10th International Symposium on Atherosclerosis. Woodford FP, Davignon J, Sniderman A, Eds. Amsterdam, Elsevier, 1995, p. 121-125
14. Russell JC, Amy RM: Early atherosclerotic lesions in a susceptible rat model: the LA/N-corpulent rat. Atherosclerosis 60:119-129, 1988
15. Russell JC, Ahuja SK, Manickavel V, Rajotte RV, Amy RM: Insulin resistance and impaired glucose tolerance in the atherosclerosis prone LA/N-corpulent rat. Arteriosclerosis 7:620-626, 1987
16. Russell JC, Graham S, Hameed M: Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 43:538-543, 1994
17. Pedereon RA, Campos RV, Buchan AMJ, Chisholm CB, Russell JC, Brown JC: Comparison of the enteroinsular axis in two strains of obese rats: the fatty Zucker and JCR:LA-corpulent Int J Obes 15:461-470, 1991
18. Bar-Tana J, Ben-Shoshan S, Blum J, Migron Y, Hertz R, Pill J, Rose-Kahn G, Witte GC: Synthesis, hypolipidemic and antidiabetogenic activities of β,β'′-tetrasubstituted, long chain dioic acids. J Med Chem 32:2072-2084, 1989
19. Russell JC, Dolphin PJ, Hameed M, Stewart B, Koeslag DG, Rose-Kahn G, Bar-Tana J: Hypolipidemic effect of β,β′-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Artetioscler Thromb 11:602-609, 1991
20. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J: Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β′-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 15:918-923, 1995
21. Kuksis A, Myher JJ, Geher K, Hoffman AGD, Breckenridge WC, Jones GJL, Little JA: Comparative determination of plasma cholesterol and triacylglycerol levels by automated gas-liquid Chromatographic and autoanalyzer techniques. J Chromatogr 146:393-412, 1978
22. Novak M: Colorimetric ultramicro method for the determination of free fatty acids. J Lipid Res 6:431-433, 1965
23. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
24. Shillabeer G, Hornford J, Forden JM, Wong NCW, Lau DWS: Hepatic and adipose tissue lipogenic enzyme mRNA levels are suppressed by high fat diets in the rat. J Lipid Res 31:623-631, 1990
25. Hansen PA, Gulve EA, Holloazy JO: Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:979-985, 1994
26. Richardson M, Alavi MZ, Moore S: Rabbit models of atherosclerosis. In. Atherosclerosis and Arteriosclerosis: Human Pathology and Experimental Animal Models. White RH, Ed. Boca Raton, FL, White Pub CRC Press, 1989, p. 165-205
27. Wigglesworth VB: The distribution of lipid in the cell structure; an improved method for the electron microscope. Tissue Cell 13:19-21, 1981
28. De Lean A, Munson PJ, Rodbard D: Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102, 1978
29. Wu-Peng XS, Chua SC Jr, Okada N, Liu S-M, Nicolson M, Leibel RL: Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr). Diabetes 46:513-518, 1997
30. Emilsson V, Lim YL, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor in RNA in pancreatic islets and directly inhibitory action of leptin on insulin secretion. Diabetes 46:313-316, 1997
31. Russell JC, Koeslag DG, Amy RM, Dolphin PJ: Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis 9:869-876, 1989
32. Shillabeer G, Hornford J, Forden JM, Wong NCW, Lau DCW: Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. J Lipid Res 33:31-39, 1992
33. Satoh S, Inoue S, Egwa M, Takamura Y, Murase T: Insulin increases triglyceride secretion rate in rats in vivo. Int J Obes 11:325-331, 1987
34. Wolf SS, Hofer G, Beck K-F, Roder K, Schweitzer M: Insulin-responsive regions of the fatty acid synthase gene promoter. Biochem Biophys Res Comm 203:943-950, 1994
35. Després J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
36. Reaven GM, Mondon CE, Chen YD, Breslow JL: Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. J Lipid Res 35:820-824, 1994
37. Storlein LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition of development of insulin resistance in rats. Diabetes 40:280-289, 1991
38. Ong JM, Kern PA: Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest 84:305-311, 1989
39. Shillabeer G, Chamoun C, Hatch G, Lau DCW: Exogenous triacylglycerol inhibits insulin-stimulated glucose transport in L6 muscle cells in vitro. Biochem Biophys Res Comm 207:768-774, 1995